An Overview of the Summit Sessions




African American Prostate Cancer Disparity Summit

September 19th and 20th, Washington, DC

Summit Sessions Overview



 Session A: PHEN Community Education and Awareness Outreach 

PHEN has a major focus on reaching and educating men and their families where they are. This effort is implemented through its Annual Father's Day Rally with church partners, PHEN television, monthly webcasts and e-newsletters. Examining the success and future directions of these Rally Against Prostate Cancer (RAP Cancer) Initiatives will be the subject of this session. 

Session B: Active Surveillance - To Treat or Not to Treat Prostate Cancer

Delaying the immediate treatment of prostate cancer through active surveillance has gained increased support from medical experts. This session will present the concept of active surveillance, the scientific evidence supporting it and the known benefits and risks for patients. The session will also examine how this treatment option may apply to African American patients. 

Session C: New Diagnostics Tests for Informed Treatment Decisions

It has been established that there are different types of prostate cancers with varying levels of aggressiveness. While certain cancers may be highly lethal others may not be clinically significant. A new era of diagnostic tests are becoming available to help patients understand their specific type of cancer and to aid them and their doctors in making better informed decisions about selecting the most appropriate treatment approach. This session will present and examine some of the new diagnostic tests.

Session D: Clinical Trials Equity

African Americans are not fairly represented in the vast majority of prostate cancer clinical trials. This creates a statistical void in understanding the effectiveness of new treatments on the population at highest risk for the disease. This session will review certain clinical trials and strategies for increasing African American clinical trials participation.

Session E: Evaluating Early Detection Testing (Screening) Guidelines

This session will review and examine the early detection screening guidelines and recommendations by the American Cancer Society, U.S. Preventive Services Task Force, American Cancer Society and National Comprehensive Cancer Network. Each guideline will be reviewed and evaluated relative to how it specifically addresses the needs of African Americans and other high risk men.

Session F: New Developments and Evolving Trends

This session will provide an update and overview on certain new developments along with evolving trends and directions underway for new treatments and tools to support patient needs. Medical, research and industry leaders will also outline how these developments will address the African American prostate cancer disparity.

Washington, DC - Summit Venues

Thursday, September 19th

* 8:30am to 1pm

Russell Senate Building

Kennedy Caucus Room                    

* 2pm to 4pm

Washington Convention Center

Room 201

Note: A session of the "Congressional Black Caucus Annual Legislative Conference"

Friday, September 20th

* 8:30am to 12 noon

Biotechnology Industry Organization (BIO)

1201 Maryland Avenue, SW

Suite 900













































































































































































































































































































































































































































































































































































































<p style

PHEN,Inc. © 2023 All rights reserved